Table 2 Association of DAX-1 with various clinicopathological factors and with estrogen receptor-α, estrogen receptor-β and androgen receptor status
Parameter | n | Negative | Nuclear location | P | Cytoplasmic location | P |
|---|---|---|---|---|---|---|
Age (years) | ||||||
≤50 | 11 | 5 | 4 | 2 | ||
>50 | 28 | 9 | 11 | 0.699 | 8 | 0.652 |
TNM class | ||||||
T1 | 19 | 10 | 7 | 2 | ||
T2 | 16 | 6 | 6 | 4 | ||
T3 | 2 | 1 | 1 | 0 | ||
T4 | 2 | 0 | 0 | 0.8486 | 2 | 0.216 |
Nodal status (%) | ||||||
≤33 | 26 | 14 | 6 | 6 | ||
33–90 | 10 | 2 | 7 | 1 | ||
>90 | 3 | 0 | 1 | <0.05 | 2 | 0.1439 |
Histological type | ||||||
Ductal | 24 | 10 | 9 | 5 | ||
Lobular | 15 | 4 | 6 | 0.699 | 5 | 0.4028 |
Disease-free duration (months) | ||||||
5–20 | 3 | 0 | 1 | 2 | ||
20–30 | 10 | 2 | 5 | 3 | ||
>30 | 26 | 11 | 9 | 0.3081 | 6 | 0.1713 |
ER-α | ||||||
- | 10 | 5 | 3 | 2 | ||
C | 9 | 2 | 2 | 5 | ||
N | 20 | 7 | 10 | 0.6077 | 3 | 0.1649 |
ER-β | ||||||
- | 23 | 9 | 7 | 7 | ||
C | 13 | 5 | 6 | 3 | ||
N | 3 | 1 | 2 | 0.7138 | 0 | 0.6766 |
AR | ||||||
- | 20 | 12 | 6 | 2 | ||
C | 17 | 2 | 7 | 8 | ||
N | 2 | 0 | 2 | <0.05 | 0 | <0.001 |